经皮射频治疗肝癌及其活体穿刺活检结果的实验研究  

Study on the Diagnostic Value of Needle Cutting Biopsy for the Primary and Metastatic Hepatic Cancer During the Treatment of Radiofrequency Ablation and Ethanol Injection

作　　者：刘树佳[1] 陈敏山[2] 陈祥洪[1] 袁湘瑜[1] 何润沛[1] 李文媚[1] 王彤[1] 

机构地区：[1]广东省东莞市人民医院肿瘤外科,广东东莞523018 [2]中山大学肿瘤防治中心

出　　处：《中国医师杂志》2005年第4期469-471,共3页Journal of Chinese Physician

基　　金：广东省东莞市社会发展攻关基金资助项目(B2003-5)

摘　　要：目的探讨经皮超声或CT引导射频联合瘤内无水酒精注射治疗原发性肝癌及转移性肝癌的分体活检针穿刺活检的诊断价值与安全性。方法前瞻性分析48例经皮超声或CT引导射频联合瘤内无水酒精注射治疗原发性及转移性肝癌并作了穿刺活检的病人的临床资料。结果46例病人取得病理诊断,2例未能诊断,无严重并发症。结论经皮超声或CT引导射频联合瘤内无水酒精注射治疗肝癌应用分体活检针穿刺活检安全有效,诊断率高。Objectives To investigate the diagnostic value and safety of needle cutting biopsy for the primary and metastatic hepatic cancer during the treatment of percutaneous radiofrequency ablation and ethanol injection guided by ultrosound or CT. Methods The clinical data of 48 patients underwent the treatment of percutaneous radiofrequency ablation and ethanol injection as well as biopsy were analyzed. Results Among 48 patients,46 case(95.8%) were diagnosed by pathological examination and 2 cases (4.2%) failed to be diagnosed. There were no serious complications in all the patients. Conclusion Detachable needle cutting biopsy was safe and effective for the diagnosis of the primary and metastatic hepatic cancer during the treatment of percutaneous radiofrequency ablation and ethanol injection guided by ultrasound or CT.

关 键 词：穿刺活检 经皮射频治疗 实验研究 无水酒精注射治疗 转移性肝癌 活体 CT引导 前瞻性分析 原发性肝癌 病理诊断 临床资料 诊断价值 活检针 瘤内 超声 安全性 诊断率 病人 

分 类 号：R735.7[医药卫生—肿瘤]